In the study by Falini et al,11 FLT3/ITD mutations in AML patients with a mutant NPM1 gene occurred twice as often as in AML patients with wild-type NPM1, which suggests a relationship between FLT3/ITD and NPM1 mutations in tumor genesis. The gene discussed is FLT3; the disease is acute myeloid leukemia.